UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No.1 )*

Rockwell Medical Technologies,Inc.
(Name of Issuer)

Common Stock
(Title of Class of Securities)

774374102
(CUSIP Number)

January 23,2009
(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:

[ ] Rule 13d-1(b)
[x] Rule 13d-1(c)
[ ] Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be
deemed  to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however,
see the Notes).

1. NAME OF REPORTING PERSONS.  I.R.S. IDENTIFICATION NOS.
   OF ABOVE PERSONS (ENTITIES ONLY)

   Berlin Financial, Ltd.; FEIN 34-1855358

2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
   (a) [ ]
   (b) [x]

3. SEC USE ONLY

4. CITIZENSHIP OR PLACE OF ORGANIZATION

   Ohio


NUMBER OF               5 SOLE VOTING POWER                   0  shares
SHARES
BENEFICIALLY            6 SHARED VOTING POWER          415,969 shares
OWNED BY
EACH
REPORTING               7 SOLE DISPOSITIVE POWER       	       0 shares
PERSON WITH

                        8 SHARED DISPOSITIVE POWER     415,969 shares


9.      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

        415,969 shares

10.     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
        SHARES [   ]

11.     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

        3.01%

12.     TYPE OF REPORTING PERSON

        IA


Item 1(a). Name of Issuer:

Rockwell Medical Technologies,Inc.

Item 1(b). Address of Issuer's Principal Executive Offices:

Rockwell Medical Technologies,Inc.
30142 Wixom, MI
Wixom, MI 48393


Item 2(a). Name of Person Filing:

Berlin Financial, Ltd.

Item 2(b). Address of Principal Business Office:

Berlin Financial, Ltd.
1325 Carnegie Ave.
Cleveland, OH 44115

Item 2(c). Citizenship:

Ohio

Item 2(d). Title of Class of Securities:

Common Stock

Item 2(e). CUSIP Number: 774374102


Item 3.  If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b),
         check  whether the person filing is a:

(e) An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E)

Item 4. Ownership:

(a)     Amount of Beneficially Owned:           415,969 shares
(b)     Percent of Class:                   	3.01%
(c)     Number of shares as to which such person has:

     (i)  Sole power to vote or to direct the vote:              0 shares

    (ii)  Shared power to vote or to direct the vote:     415,969 shares

   (iii)  Sole power to dispose or to direct the disposition of: 0 shares

    (iv)  Shared power to dispose or to direct the disposition of: 415,969
          shares

Item 5. Ownership of Five Percent or Less of a Class.

        The Reporting Person ceased to be a beneficial owner of more
than 5% of Rockwell Medical,Technologies,Inc. common stock as of
January 23,2009.

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

        Not applicable

Item 7. Identification and Classification of the Subsidiary Which Acquired the
        Security Being Reported on by the Parent Holding Company or Control
        Person.

        Not applicable

Item 8. Identification and Classification of Members of the Group.

        Not applicable

Item 9. Notice of Dissolution of Group.

        Not applicable

Item 10.Certification.

        By signing below I certify that to the best of my knowledge and belief,
        the securities referred to above were acquired in the ordinary course
        of business and were not acquired for the purpose of and do not have
        the effect of changing or influencing the control of the issuer of
        such securities and were not acquired in connection with or as a
        participant in any transaction having such purpose or effect.

        Signature:  /s/ Thomas G. Berlin

        After reasonable inquiry and to the best of my knowledge and belief, I
        certify that the information set forth in this statement is true,
        complete and correct.

        Date: January 30, 2009

        Signature:  /s/ Thomas G. Berlin


        Title:   Managing Member